USD92.58 ₽ EUR100.28 ₽ telegram Telegram
2024-03-21 обновлены отчеты компании ARMP: 20232022
Armata Pharmaceuticals  logo
Armata Pharmaceuticals ARMP
$ 2.49 -1.19%

Armata Pharmaceuticals Мультипликаторы 2011-2024 | ARMP

Мультипликаторы по годам Armata Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-1.9 -1.8 -5.1 -4.1 -1.3 -0.4 -0.6 -0.2 -31.5 1.5 -1.1 -6.1 -2.6

P/S

- - - 109.7 - - 67.2 17.4 34.2 82.4 196.2 10.1 81.7

EPS

-1.9 -1.1 -1.0 -1.4 -2.5 -3.6 -2.0 -24.7 -2.0 4.2 -0.6 - -

EV (Enterprise Value)

250 млн 110 млн 151 млн 101 млн 29.7 млн 1.23 тыс. 6 млн 7.29 млн 25.6 млн 52.3 млн 95.6 млн 15.9 млн 14.1 млн

EBITDA per Share

-1.11 -1.05 -0.94 -1.11 -2.65 -7.53 -21.9 -192 -256 -521 -1.03 тыс. -573 -383

EV/EBITDA

-5.8 -4.0 -1.1 0.3 -0.3 0.0 -0.7 -1.9 -2.9 -2.4 -3.0

PEG

0.08 0.05 0.09 -0.09 -0.02 -0.01 -0.01 0.01 0.24 0.01 0.0 -0.1 -0.03

P/B

-4.2 1.8 4.6 4.8 1.7 0.6 1.0 0.5 1.3 9.8 -4.5 0.5 1.4

P/CF

-2.8 -2.0 -5.0 -4.7 -1.6 -0.5 -0.8 -0.4 -1.6 -2.4 -8.4 -1.6 -2.1

ROE %

215.33 -102.32 -91.17 -117.63 -133.48 -142.91 -166.06 -193.75 -4.06 672.36 410.74 -8.58 -53.01

ROA %

-70.19 -38.52 -33.19 -56.13 -76.54 -101.88 -115.26 -103.53 -1.64 80.75 -153.93 -5.03 -33.01

ROCE %

127.52 -102.40 -93.80 -65.79 -92.79 -113.73 -112.93 -94.64 -35.13 -52.75 -41.86 -25.12 -39.22

Current Ratio

0.8 1.6 1.6 1.6 1.4 3.3 2.7 1.8 4.2 3.8 9.6 0.3 1.1

DSO

- - - 248.8 - - - 35.1 96.1 89.2 9.0 352.4 365.0

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Armata Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.86 -0.1 -0.4 - -0.24 -0.26 -0.3 - -0.22 -0.25 -0.27 - -0.31 -0.26 -0.49 - -0.73 -0.56 -0.11 - -0.6 -0.68 -0.24 - -0.09 -1.21 -1.94 -0.7 -3.23 -7.26 -0.82 -0.54 -0.3 1.27 -3.49 -0.25 3.87 2.56 -3.18 - -0.49 -0.16 -0.64 - - - - - - - -

EBITDA per Share

-0.28 -0.26 -0.31 - -0.23 -0.25 -0.29 - -0.24 -0.24 -0.25 - -0.29 -0.23 -0.44 - -0.67 -0.64 -0.1 - -0.45 -0.52 -0.22 - -0.06 -1.78 -1.95 -7.2 -2.84 -3.93 -0.76 -0.5 -0.38 -0.44 -0.52 -0.65 -1.38 -1 -0.01 - -0.02 -0.07 -0.12 - - - - - - - -

ROE %

149.60 -120.88 -119.64 -50.45 -73.26 -77.17 -81.52 -60.61 -91.20 -98.99 -102.32 -82.50 -130.16 -147.23 -151.02 -102.06 -138.07 -126.43 -138.81 -114.16 -124.24 -98.30 -140.71 -135.64 -233.34 -247.69 -203.73 -193.75 -113.59 -93.22 -57.67 -29.72 -31.49 644.92 1321.34 1997.76 2302.53 1915.62 1528.71 856.35 856.35 570.90 285.45 - - - - - - - -

ROA %

-53.73 -35.37 -40.99 -26.54 -39.24 -42.67 -46.37 -35.93 -50.53 -52.43 -51.52 -39.37 -66.70 -79.42 -84.00 -58.52 -77.57 -69.29 -74.57 -67.19 -74.18 -62.13 -98.36 -94.15 -146.48 -152.57 -115.77 -103.73 -58.49 -47.04 -27.46 -12.00 -7.24 75.16 157.55 239.94 85.55 -151.91 -389.36 -470.12 -470.12 -313.41 -156.71 - - - - - - - -

ROCE %

-18.92 -37.84 -55.14 -50.48 -76.34 -83.28 -87.63 -63.49 -93.31 -97.27 -99.96 -80.26 -126.70 -143.32 -154.32 -105.37 -136.94 -122.07 -123.67 -104.57 -114.22 -92.30 -180.64 -178.39 -300.41 -325.80 -237.42 -240.44 -141.54 -125.60 -109.08 -80.44 -132.87 -133.29 -119.97 -105.62 -38.28 -26.98 -41.41 -74.92 -74.92 -66.70 -45.20 - - - - - - - -

Current Ratio

0.9 1.2 1.3 1.6 2.0 2.1 2.3 1.6 2.3 2.5 2.8 1.9 1.9 1.9 1.9 2.3 2.3 2.3 2.3 2.1 2.1 2.1 3.5 3.3 3.3 3.3 3.3 2.1 2.1 2.1 2.1 4.6 4.6 4.6 4.6 1.2 1.2 1.2 1.2 0.7 0.7 0.7 0.7 - - - - - - - -

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD